Showing 25 to 36 of 69 results
Sleep Disturbances Significantly Increase Dementia Risk
Studies reveal a strong correlation between sleep disturbances (insomnia, sleep apnea) and increased dementia risk, with disrupted sleep in midlife linked to lower cognitive scores a decade later; deep sleep flushes out amyloid proteins, while REM sleep is crucial for memory processing, both impacti...
Sleep Disturbances Significantly Increase Dementia Risk
Studies reveal a strong correlation between sleep disturbances (insomnia, sleep apnea) and increased dementia risk, with disrupted sleep in midlife linked to lower cognitive scores a decade later; deep sleep flushes out amyloid proteins, while REM sleep is crucial for memory processing, both impacti...
Progress
28% Bias Score
EU Approves Lecanemab for Early-Stage Alzheimer's; Strict Criteria Apply
The European Commission approved Lecanemab, a new Alzheimer's drug targeting amyloid plaques, for patients with minimal cognitive impairment and low ApoE4 gene copies; it offers a five-month delay in cognitive decline but is restricted due to potential side effects.
EU Approves Lecanemab for Early-Stage Alzheimer's; Strict Criteria Apply
The European Commission approved Lecanemab, a new Alzheimer's drug targeting amyloid plaques, for patients with minimal cognitive impairment and low ApoE4 gene copies; it offers a five-month delay in cognitive decline but is restricted due to potential side effects.
Progress
36% Bias Score
EU Approves First Alzheimer's Disease Treatment Targeting Disease Processes
The European Commission approved Lecanemab, a new Alzheimer's treatment targeting disease processes, for use in the EU; although effective in slowing progression in early stages for a small subset of patients, it is not a cure and its long-term effects remain uncertain.
EU Approves First Alzheimer's Disease Treatment Targeting Disease Processes
The European Commission approved Lecanemab, a new Alzheimer's treatment targeting disease processes, for use in the EU; although effective in slowing progression in early stages for a small subset of patients, it is not a cure and its long-term effects remain uncertain.
Progress
44% Bias Score
Semaglutide Linked to Reduced Dementia Risk in Major Studies
Two large-scale studies suggest that the weight-loss drug semaglutide, found in Wegovy and Ozempic, may significantly lower the risk of developing dementia, offering a potential preventative measure against a condition costing the UK £42 billion annually.
Semaglutide Linked to Reduced Dementia Risk in Major Studies
Two large-scale studies suggest that the weight-loss drug semaglutide, found in Wegovy and Ozempic, may significantly lower the risk of developing dementia, offering a potential preventative measure against a condition costing the UK £42 billion annually.
Progress
32% Bias Score
Lower LDL Cholesterol Significantly Reduces Dementia Risk: Large-Scale Study
A study of almost 109,000 people found that lower LDL cholesterol levels were associated with a 26% lower risk of dementia and a 28% lower risk of Alzheimer's disease; statin use further reduced the risk.
Lower LDL Cholesterol Significantly Reduces Dementia Risk: Large-Scale Study
A study of almost 109,000 people found that lower LDL cholesterol levels were associated with a 26% lower risk of dementia and a 28% lower risk of Alzheimer's disease; statin use further reduced the risk.
Progress
16% Bias Score
Insufficient Deep Sleep Accelerates Alzheimer's Brain Deterioration
A new study shows that inadequate slow-wave and REM sleep accelerates Alzheimer's-related brain deterioration, specifically affecting the inferior parietal lobe responsible for sensory information processing; this emphasizes the importance of sufficient sleep for brain health.
Insufficient Deep Sleep Accelerates Alzheimer's Brain Deterioration
A new study shows that inadequate slow-wave and REM sleep accelerates Alzheimer's-related brain deterioration, specifically affecting the inferior parietal lobe responsible for sensory information processing; this emphasizes the importance of sufficient sleep for brain health.
Progress
28% Bias Score
Biological Age, Not Chronological Age, a Key Dementia Risk Factor
A study of 280,000 UK residents found a 30% increased dementia risk for those with a higher biological age (average 55) compared to a lower biological age (average 45), emphasizing the impact of cellular aging over chronological age in dementia development.
Biological Age, Not Chronological Age, a Key Dementia Risk Factor
A study of 280,000 UK residents found a 30% increased dementia risk for those with a higher biological age (average 55) compared to a lower biological age (average 45), emphasizing the impact of cellular aging over chronological age in dementia development.
Progress
36% Bias Score
Repurposed Drugs Offer Hope in Fight Against UK's Top Killer, Dementia
Dementia is the UK's biggest killer, but research suggests existing drugs like aspirin, statins, and Ozempic could prevent it, offering a cheaper alternative to recently developed, costly medications.
Repurposed Drugs Offer Hope in Fight Against UK's Top Killer, Dementia
Dementia is the UK's biggest killer, but research suggests existing drugs like aspirin, statins, and Ozempic could prevent it, offering a cheaper alternative to recently developed, costly medications.
Progress
48% Bias Score
Study Reveals Non-Linear Brain Aging, Potential for Ketone-Based Interventions
A study of 19,300 individuals reveals non-linear brain aging, with sharp declines around ages 44 and 67, potentially linked to insulin resistance and treatable with ketone supplementation.
Study Reveals Non-Linear Brain Aging, Potential for Ketone-Based Interventions
A study of 19,300 individuals reveals non-linear brain aging, with sharp declines around ages 44 and 67, potentially linked to insulin resistance and treatable with ketone supplementation.
Progress
40% Bias Score
Shingles Vaccine Linked to Lower Dementia Risk
A Welsh study published in Nature found a 3.5% lower dementia risk in individuals who received the shingles vaccine compared to those who didn't, suggesting that viral infections might play a more significant role in dementia than previously thought.
Shingles Vaccine Linked to Lower Dementia Risk
A Welsh study published in Nature found a 3.5% lower dementia risk in individuals who received the shingles vaccine compared to those who didn't, suggesting that viral infections might play a more significant role in dementia than previously thought.
Progress
52% Bias Score
Shingles Vaccine Linked to Reduced Dementia Risk in Women
A UK study published in Nature found that the Varicella Zoster (shingles) vaccine significantly reduced dementia risk in women (20% lower incidence) over seven years, suggesting a link between the virus and dementia and prompting calls for expanded vaccination recommendations.
Shingles Vaccine Linked to Reduced Dementia Risk in Women
A UK study published in Nature found that the Varicella Zoster (shingles) vaccine significantly reduced dementia risk in women (20% lower incidence) over seven years, suggesting a link between the virus and dementia and prompting calls for expanded vaccination recommendations.
Progress
48% Bias Score
Statins May Reduce Alzheimer's Risk by a Third: Landmark Study
A South Korean study of 570,000 people found that low LDL cholesterol levels, especially when achieved with statins, reduced the risk of Alzheimer's by 28% and an additional 12% respectively, suggesting statins may protect against the disease by reducing brain cholesterol.
Statins May Reduce Alzheimer's Risk by a Third: Landmark Study
A South Korean study of 570,000 people found that low LDL cholesterol levels, especially when achieved with statins, reduced the risk of Alzheimer's by 28% and an additional 12% respectively, suggesting statins may protect against the disease by reducing brain cholesterol.
Progress
40% Bias Score
Showing 25 to 36 of 69 results